Reacta Healthcare appoints Iedena Lima as head of research and development Reacta Healthcare appoints Iedena Lima as head of research and development Extensive pharma and medtech sector experience strengthens senior leadership to support growth and strategic expansion Clinilabs announces medical leadership appointments Clinilabs announces medical leadership appointments Bob Dagher, M.D., named chief medical officer and Waqar Ahmed Siddiqui, M.D., named principal investigator FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies today announced a planned leadership evolution as the Company enters its next phase of execution and sustainable growth Fresenius Medical Care appoints Cassie McLean as Management Board member for Care Delivery Fresenius Medical Care appoints Cassie McLean as Management Board member for Care Delivery Cassie McLean succeeds Craig Cordola as CEO of Care Delivery, effective 1 August 2026 IMCD appoints Vlad Miller as president, US IMCD appoints Vlad Miller as president, US Vlad Miller takes on the role of President, US, following five months leading the business on an interim basis Actimed strengthens board with appointment of Dr Anders Ullman Actimed strengthens board with appointment of Dr Anders Ullman Pharmaceutical executive brings more than 30 years of international drug development and corporate leadership experience Simris Group appoints biotechnology expert Dr. Tiffany J. Vora as strategic advisor Simris Group appoints biotechnology expert Dr. Tiffany J. Vora as strategic advisor Appointment strengthens Simris Group's engagement with the US biotechnology ecosystem and supports advancement of its ADC platform CluePoints appoints Martin Magazzolo as Chief Commercial Officer CluePoints appoints Martin Magazzolo as Chief Commercial Officer New CCO to lead global commercial strategy as CluePoints expands its RBQM and clinical data quality oversight solutions DFE Pharma appoints Khatera Alawi as new Global Director Human Resources DFE Pharma appoints Khatera Alawi as new Global Director Human Resources An experienced international HR leader, Alawi joins DFE Pharma’s Leadership Team to support the company’s people-centric, high-performance culture ACG appoints Lalit Kasliwal as Group Chief Financial Officer ACG appoints Lalit Kasliwal as Group Chief Financial Officer New appointment to support ACG’s next phase of international growth Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Andreas Reisse to retire as CEO of SCHOTT Pharma as planned. Christian Mias, Executive Vice President of SCHOTT’s Electronic Packaging Business Unit, appointed as new CEO of... Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer... How strong leadership transforms regulatory and operational challenges How strong leadership transforms regulatory and operational challenges Why SLTs fail on the PQS/QMS: The leadership gap undermining quality Siddharth Mittal appointed as Managing Director & CEO of Syngene International Siddharth Mittal appointed as Managing Director & CEO of Syngene International Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), today announced that Siddharth Mittal has assumed the role of Managing... Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery Aplagon appoints Carl Lindgren as Board Chair to guide later stage clinical and corporate development Aplagon appoints Carl Lindgren as Board Chair to guide later stage clinical and corporate development Veteran life sciences executive brings over 30 years of strategic and commercial leadership as Aplagon advances through Phase 2 development in multiple thrombosis-inflammatory...